Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Health Literacy's Impact on Exercise Habits and Medication Adherence in Postmenopausal Osteoporosis

The Relationship Between Health Literacy, Exercise Habits, and Medication Adherence in Postmenopausal Osteoporosis Patients

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Postmenopausal osteoporosis is characterized by low bone mass and increased fracture risk. Treatment includes exercise, nutrition, supplements, and medications like bisphosphonates, denosumab, or hormone replacement therapy. Lifestyle changes such as quitting smoking, reducing alcohol consumption, and preventing falls are also crucial. Despite effective treatments, adherence is low: 20-30% of patients don't start oral bisphosphonates, and 16-60% continue medications after one year. Exercise adherence rates are similarly low (14.3%-57.7%). This non-adherence imposes a significant clinical and economic burden. Health literacy (HL)-the ability to find, understand, and use health information-is vital for managing health but is understudied in relation to osteoporosis treatment adherence. This study aims to examine the relationship between HL, exercise habits, and medication adherence in postmenopausal osteoporosis patients. Understanding these factors can lead to effective interventions, improving patient adherence and health outcomes. The study will measure HL levels and their correlation with medication and exercise adherence, potentially informing health education programs and strategies to enhance treatment adherence. By doing so, it aims to improve health outcomes and healthcare system efficiency.

Who May Be Eligible (Plain English)

Who May Qualify: - Postmenopausal patients - Being under outpatient follow-up for osteoporosis for at least one year Who Should NOT Join This Trial: - Orthopedic, rheumatic, and neurological conditions that may hinder participation in exercise - Cancer - Refusal to participate in the study Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Postmenopausal patients * Being under outpatient follow-up for osteoporosis for at least one year Exclusion Criteria: * Orthopedic, rheumatic, and neurological conditions that may hinder participation in exercise * Cancer * Refusal to participate in the study

Locations (1)

Gazi University
Ankara, Yenimahalle, Turkey (Türkiye)